Global Human Growth Hormone Market, Forecast Till 2025

  • Category : Healthcare and Pharma
  • |
  • ID : 794903
  • |
  • Publishe Date : February 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Human Growth Hormone Market was valued at USD XX million in 2017, and is expected to grow at a CAGR of XX% by 2025. Advancements in technology including development of recombinant Human Growth Hormone by the major players is boosting the market growth.
Rising incidences of HIV/AIDS, growing research and development of long acting drugs, increasing cases of cancer, improving expenditure on healthcare, and commonly found growth hormone deficiencies have all augmented the global human growth hormone market.
Factors, such as high cost of these drugs and therapies may hinder the growth of the overall market.
Technological advancements such as the development of recombinant human growth hormone by market players is further expected to boost the market growth in coming years.

On the basis of Application, the market is segmented into growth hormone deficiency, Idiopathic Short Stature (ISS), Turner syndrome, Prader-Willi syndrome, among others. In 2016, growth hormone deficiency segment accounted for the largest market share and is expected to maintain its dominance during the forecast period.

On the basis of End-user, the Human Growth Hormone market is divided into hospitals, clinics, research institute, among others.
Regionally Asia Pacific is anticipated to witness the fastest growth during the forecast period as the demand for GH is rising in the emerging countries for the past few years.
Some of the key players operating in this market include Eli Lilly and Company, Ferring Holding SA, Genentech, Inc., Merck & Co., Inc.; Novo Nordisk, Pfizer, Inc.; Sandoz International GmbH, and Ipsen
Key Benefits of the Report:
* Global, Regional, Country, Application, and Route of End-user Market Size and Forecast from 2014-2025
* Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
* Identification of key companies that can influence this market on a global and regional scale
* Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
* Detailed insights on emerging regions, Application& End-user, and competitive landscape with qualitative and quantitative information and facts

Target Audience:
* Human Growth Hormone providers
* Traders, Importer and Exporter
* Raw material suppliers and distributors
* Research and consulting firms
* Government and research organizations
* Associations and industry bodies


Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity End-user, spending were taken into consideration.
We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.
The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:
* Original Manufacturer,
* Application Supplier,
* Distributors,
* Government Body & Associations, and
* Research Institute
* Pharmacies

TABLE OF CONTENT

1 EXECUTIVE SUMMARY

2 METHODOLOGY AND MARKET SCOPE
2.1 Research Methodology
2.2 Research Scope & Assumptions

3 HUMAN GROWTH HORMONE MARKET — INDUSTRY OUTLOOK
3.1 Market Segmentation and Scope
3.2 Market Size & Growth Prospects
3.3 Human Growth Hormone Market — Value Chain / Supply Chain Analysis
3.3.1 Company Landscape
3.4 Human Growth Hormone Market — Market Dynamics
3.4.1 Market Driver
3.4.2 Market Restraints
3.4.3 Market Challenges
3.5 Human Growth Hormone Market Company Market Share, 2017
3.6 Human Growth Hormone Market — Porter\'s Five Forces Analysis
3.7 Human Growth Hormone Market — Pestel Analysis

4 HUMAN GROWTH HORMONE MARKET APPLICATION OUTLOOK
4.1 Human Growth Hormone Market Share by Application, 2016 & 2025
4.2 Growth Hormone Deficiency
4.3 Idiopathic Short Stature (Iss)
4.4 Turner Syndrome
4.5 Prader-Willi Syndrome
4.6Others


5 HUMAN GROWTH HORMONE MARKET END-USER OUTLOOK
5.1 Human Growth Hormone Market Share by End-user, 2016 & 2025
5.2 Hospitals
5.3 Clinics
5.4 Pharmacies
5.5 Research and institute

6 HUMAN GROWTH HORMONE MARKET REGIONAL OUTLOOK
6.1 Human Growth Hormone Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 North America Human Growth Hormone Market, 2014 - 2025
6.2.2 North America Human Growth Hormone Market, By Application, 2014 - 2025
6.2.3 North America Human Growth Hormone Market, By End-user, 2014 - 2025
6.2.5 U.S.
6.2.5.1 U.S. Human Growth Hormone Market, By Application, 2014 - 2025
6.2.5.2 U.S. Human Growth Hormone Market, By End-user, 2014 - 2025
6.2.6 Canada
6.2.6.1 Canada Human Growth Hormone Market, By Application, 2014 - 2025
6.2.6.2 Canada Human Growth Hormone Market, By End-user, 2014 - 2025
6.3 Europe
6.3.1 Europe Human Growth Hormone Market, 2014 - 2025
6.3.2 Europe Human Growth Hormone Market, By Application, 2014 - 2025
6.3.3 Europe Human Growth Hormone Market, By End-user, 2014 - 2025
6.3.5 Germany
6.3.5.1 Germany Human Growth Hormone Market, By Application, 2014 - 2025
6.3.5.2 Germany Human Growth Hormone Market, By End-user, 2014 - 2025
6.3.6 UK
6.3.6.1 UK Human Growth Hormone Market, By Application, 2014 - 2025
6.3.6.2 UK Human Growth Hormone Market, By End-user, 2014 - 2025
6.4 Asia Pacific
6.4.1 Asia Pacific Human Growth Hormone Market, 2014 - 2025
6.4.2 Asia Pacific Human Growth Hormone Market, By Application, 2014 - 2025
6.4.3 Asia Pacific Human Growth Hormone Market, By End-user, 2014 - 2025
6.4.5 Australia
6.4.5.1 Australia Human Growth Hormone Market, By Application, 2014 - 2025
6.4.5.2 Australia Human Growth Hormone Market, By End-user, 2014 - 2025
6.4.6 New Zealand
6.4.6.1 New Zealand Human Growth Hormone Market, By Application, 2014 -
2025
6.4.6.2 New Zealand Human Growth Hormone Market, By End-user, 2014 -2025
6.4.7 China
6.4.7.1 China Human Growth Hormone Market, By Application, 2014 - 2025
6.4.7.2 China Human Growth Hormone Market, By End-user, 2014 - 2025
6.4.8 India
6.4.8.1 India Human Growth Hormone Market, By Application, 2014 - 2025
6.4.8.2 India Human Growth Hormone Market, By End-user, 2014 - 2025
6.4.9 Japan
6.4.9.1 Japan Human Growth Hormone Market, By Application, 2014 - 2025
6.4.9.2 Japan Human Growth Hormone Market, By End-user, 2014 - 2025
6.5 South America
6.5.1 South America Human Growth Hormone Market, 2014 - 2025
6.5.2 South America Human Growth Hormone Market, By Application, 2014 - 2025
6.5.3 South America Human Growth Hormone Market, By End-user, 2014 - 2025
6.5.5 Brazil
6.5.5.1 Brazil Human Growth Hormone Market, By Application, 2014 - 2025
6.5.5.2 Brazil Human Growth Hormone Market, By End-user, 2014 - 2025
6.5.6 Mexico
6.5.6.1 Mexico Human Growth Hormone Market, By Application, 2014 - 2025
6.5.6.2 Mexico Human Growth Hormone Market, By End-user, 2014 - 2025
6.6 MEA
6.6.1 MEA Human Growth Hormone Market, 2014 - 2025
6.6.2 MEA Human Growth Hormone Market, By Application, 2014 - 2025
6.6.3 MEA Human Growth Hormone Market, By End-user, 2014 - 2025

7 COMPETITIVE LANDSCAPE
7.1 Eli Lilly and Company
7.1.2 Financial performance
7.1.3 Application benchmarking
7.1.4 Strategic initiatives
7.2 Ferring Holding SA
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Application benchmarking
7.2.4 Strategic initiatives
7.3 Genentech, Inc
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Application benchmarking
7.3.4 Strategic initiatives
7.4 Merck & Co., Inc
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Application benchmarking
7.4.4 Strategic initiatives
7.5 Novo Nordisk
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Application benchmarking
7.5.4 Strategic initiatives
7.6 Pfizer, Inc
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Application benchmarking
7.6.4 Strategic initiatives
7.7 Sandoz International GmbH
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Application benchmarking
7.7.4 Strategic initiatives


End of the report
Disclaimer.

Content are not available

Choose License Type